Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -684.44% is 85% above its 5-year average of -4473.46%, near the high end of its 5-year range (-51311.65%–-9.97%).
69.14% above its 12-month average of -2217.69%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -529.15%.
EBITDA MARGIN
-684.44%
EBITDA MARGIN AVG TTM
-2217.69%
EBITDA MARGIN AVG 3Y
-9932.24%
EBITDA MARGIN AVG 5Y
-4473.46%
EBITDA MARGIN AVG 10Y
-1740.10%
EBITDA MARGIN AVG 15Y
-547.72%
EBITDA MARGIN AVG 20Y
-643.50%
CURRENT VS TTM AVG
+69.14%
CURRENT VS 3Y AVG
+93.11%
CURRENT VS 5Y AVG
+84.70%
CURRENT VS 10Y AVG
+60.67%
CURRENT VS 15Y AVG
-24.96%
CURRENT VS 20Y AVG
-6.36%
Cytokinetics, Incorporated
Market Cap
$7.61B
EBITDA Margin
-684.44%
TTM Avg
-2217.69%
3Y Avg
-9932.24%
5Y Avg
-4473.46%
Market Cap
$7.60B
EBITDA Margin
-92.07%
TTM Avg
-49.82%
3Y Avg
-47.83%
5Y Avg
-47.83%
Market Cap
$7.65B
EBITDA Margin
36.33%
TTM Avg
34.52%
3Y Avg
30.06%
5Y Avg
28.41%
Market Cap
$7.69B
EBITDA Margin
-2336.10%
TTM Avg
-3741.43%
3Y Avg
-3741.43%
5Y Avg
-3741.43%
Market Cap
$7.32B
EBITDA Margin
-38.32%
TTM Avg
-51.29%
3Y Avg
-52.67%
5Y Avg
-38.88%
Market Cap
$7.92B
EBITDA Margin
8.34%
TTM Avg
-21.08%
3Y Avg
-58.51%
5Y Avg
-29.82%
Market Cap
$8.40B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$6.66B
EBITDA Margin
15.93%
TTM Avg
16.80%
3Y Avg
17.55%
5Y Avg
18.41%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.61B | -684.44% | -2217.69% | -9932.24% | -4473.46% |
| Hinge Health, Inc. (HNGE)vs › | $7.60B | -92.07% | -49.82% | -47.83% | -47.83% |
| HealthEquity, Inc. (HQY)vs › | $7.65B | 36.33% | 34.52% | 30.06% | 28.41% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.69B | -2336.10% | -3741.43% | -3741.43% | -3741.43% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.32B | -38.32% | -51.29% | -52.67% | -38.88% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.92B | 8.34% | -21.08% | -58.51% | -29.82% |
| Alkermes plc (ALKS)vs › | $7.00B | 19.05% | 23.95% | 20.94% | 15.97% |
| Oscar Health, Inc. (OSCR)vs › | $8.40B | -3.14% | -1.08% | -5.02% | -19.32% |
| Chemed Corporation (CHE)vs › | $6.66B | 15.93% | 16.80% | 17.55% | 18.41% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.61B | 6.82% | 6.08% | -0.44% | -8.67% |
Gross Margin
85.0%
EBITDA Margin
-684.4%
Operating Margin
-695.4%
Net Margin
-1259.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -529.15% |
| 2026-03-31 | -931.23% |
| 2025-12-31 | -989.51% |
| 2025-09-30 | -8475.00% |
| 2025-06-30 | -163.58% |
| 2025-03-31 | -9710.64% |
| 2024-12-31 | -807.33% |
| 2024-09-30 | -29889.85% |
| 2024-06-30 | -51311.65% |
| 2024-03-31 | -14838.80% |
| 2023-12-31 | -7241.81% |
| 2023-09-30 | -31854.76% |
| 2023-06-30 | -13755.25% |
| 2023-03-31 | -2637.98% |
| 2022-12-31 | -6351.00% |
| 2022-09-30 | -4228.75% |
| 2022-06-30 | -9.97% |
| 2022-03-31 | -6645.38% |
| 2021-12-31 | -34.20% |
| 2021-09-30 | -1264.28% |
| 2021-06-30 | -1908.34% |
| 2021-03-31 | -612.00% |
| 2020-12-31 | -534.60% |
| 2020-09-30 | 13.72% |
| 2020-06-30 | -889.01% |
| 2020-03-31 | -783.11% |
| 2019-12-31 | -447.33% |
| 2019-09-30 | -389.61% |
| 2019-06-30 | -370.41% |
| 2019-03-31 | -286.29% |
| 2018-09-30 | -165.83% |
| 2018-06-30 | -366.77% |
| 2018-03-31 | -483.26% |
| 2017-12-31 | 199538.89% |
| 2017-09-30 | -452.65% |
| 2017-06-30 | -810.84% |
| 2017-03-31 | -549.72% |
| 2016-12-31 | 23.88% |
| 2016-09-30 | 55.32% |
| 2016-06-30 | -186.85% |
| 2016-03-31 | -139.94% |
| 2015-12-31 | -90.91% |
| 2015-09-30 | -110.03% |
| 2015-06-30 | -159.61% |
| 2015-03-31 | -198.55% |
| 2014-12-31 | 39.33% |
| 2014-09-30 | -62.37% |
| 2014-06-30 | -106.38% |
| 2014-03-31 | -108.60% |
| 2013-12-31 | 26.78% |
| 2013-09-30 | -279.93% |
| 2013-06-30 | -1481.47% |
| 2013-03-31 | -1525.33% |
| 2012-12-31 | -458.06% |
| 2012-09-30 | -579.52% |
| 2012-06-30 | -478.65% |
| 2012-03-31 | -536.37% |
| 2011-12-31 | -1541.35% |
| 2011-09-30 | -729.71% |
| 2011-06-30 | -1258.97% |
| 2011-03-31 | -1484.80% |
| 2010-12-31 | -1016.29% |
| 2010-09-30 | -3069.54% |
| 2010-06-30 | -2743.94% |
| 2010-03-31 | -1899.19% |
| 2009-12-31 | -1163.83% |
| 2009-09-30 | -139.97% |
| 2009-06-30 | 80.71% |
| 2009-03-31 | -335.54% |
| 2008-12-31 | -335.56% |
| 2008-09-30 | -514.98% |
| 2008-06-30 | -501.04% |
| 2008-03-31 | -474.13% |
| 2007-12-31 | -459.77% |
| 2007-09-30 | -303.39% |
| 2007-06-30 | -434.97% |
| 2007-03-31 | -405.90% |
| 2006-12-31 | -10499.35% |
| 2006-09-30 | -14410.38% |
| 2006-06-30 | -978.22% |
| 2006-03-31 | -895.56% |
| 2005-12-31 | -510.87% |
| 2005-09-30 | -537.41% |
| 2005-06-30 | -441.26% |
| 2005-03-31 | -401.24% |
| 2004-12-31 | -515.50% |
| 2004-09-30 | -401.31% |
| 2004-06-30 | -300.21% |
| 2004-03-31 | -87.76% |
| 2003-12-31 | -1532.64% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | -185.28% |
| 2003-03-31 | -182.14% |
